Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Vall-Llovera

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Hemasphere|May 27, 2025
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trialsCelia González-Gil, Thaysa Lopes, Mireia Morgades, et al.
Haematologica|November 3, 2022
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsCelia González-Gil, Mireia Morgades, Thaysa Lopes, et al.
Hematological Oncology|August 18, 2021
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trialsJosep-Maria Ribera, Mireia Morgades, Eulàlia Genescà, et al.
American Journal of Hematology|November 22, 2025
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 PatientsMatteo Molica, Gema Miralles, Richard Dillon, et al.
Cancer Medicine|May 22, 2023
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registryTeresa Bernal, Ainhoa Fernández Moreno, Almudena de LaIglesia, et al.
Blood|November 5, 2020
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Juana Ciudad, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Hemasphere|May 27, 2025
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trialsCelia González-Gil, Thaysa Lopes, Mireia Morgades, et al.
Haematologica|November 3, 2022
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsCelia González-Gil, Mireia Morgades, Thaysa Lopes, et al.
Hematological Oncology|August 18, 2021
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trialsJosep-Maria Ribera, Mireia Morgades, Eulàlia Genescà, et al.
American Journal of Hematology|November 22, 2025
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 PatientsMatteo Molica, Gema Miralles, Richard Dillon, et al.
Cancer Medicine|May 22, 2023
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registryTeresa Bernal, Ainhoa Fernández Moreno, Almudena de LaIglesia, et al.
Blood|November 5, 2020
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Juana Ciudad, et al.
Pageof 3